Collaborative Stage for TNM 7 - Revised 11/18/2010

MyelomaPlasmaCellDisorder

Plasma Cell Disorders including Myeloma

CS Tumor Size = 988
CS Extension
CS Tumor Size/Ext Eval = 9
CS Lymph Nodes
CS Lymph Nodes Eval = 9
Regional Nodes Positive = 99
Regional Nodes Examined = 99
CS Mets at DX
CS Mets Eval = 9
CS Site-Specific Factor 1
OBSOLETE - Janus Kinase 2 (JAK2) (also known as JAK2 Exon 12)
CS Site-Specific Factor 2
Durie-Salmon Staging System
CS Site-Specific Factor 3
Multiple Myeloma Terminology
CS Site-Specific Factor 4 = 988
CS Site-Specific Factor 5 = 988
CS Site-Specific Factor 6 = 988
CS Site-Specific Factor 7 = 988
CS Site-Specific Factor 8 = 988
CS Site-Specific Factor 9 = 988
CS Site-Specific Factor 10 = 988
CS Site-Specific Factor 11 = 988
CS Site-Specific Factor 12 = 988
CS Site-Specific Factor 13 = 988
CS Site-Specific Factor 14 = 988
CS Site-Specific Factor 15 = 988
CS Site-Specific Factor 16 = 988
CS Site-Specific Factor 17 = 988
CS Site-Specific Factor 18 = 988
CS Site-Specific Factor 19 = 988
CS Site-Specific Factor 20 = 988
CS Site-Specific Factor 21 = 988
CS Site-Specific Factor 22 = 988
CS Site-Specific Factor 23 = 988
CS Site-Specific Factor 24 = 988
CS Site-Specific Factor 25 = 988
Histology Inclusion Table AJCC 7th ed. = NA
Histology Exclusion Table AJCC 6th ed. = NA
AJCC TNM 7 Stage = NA
AJCC TNM 6 Stage = NA
Summary Stage
Revision Info   List of Schemas